Clinical trials
Phase 1 Oropharyngeal Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 5 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 6 |
| Emory University | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| AstraZeneca | 1 |
| Celldex Therapeutics | 1 |
| Inhibrx Biosciences, Inc | 1 |
| M.D. Anderson Cancer Center | 1 |
| Nanobiotix | 1 |
| Ohio State University Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Oropharyngeal Neoplasms | 25 |
| Laryngeal Neoplasms | 14 |
| Mouth Neoplasms | 14 |
| Hypopharyngeal Neoplasms | 13 |
| Head and Neck Neoplasms | 10 |
| Squamous Cell Carcinoma of Head and Neck | 10 |
| Carcinoma | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Carcinoma, Renal Cell | 5 |
| Nasopharyngeal Neoplasms | 5 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.